{"id":11581,"date":"2024-04-19T18:21:32","date_gmt":"2024-04-19T10:21:32","guid":{"rendered":"https:\/\/medicare-asia.com\/?p=11581"},"modified":"2024-12-12T09:17:26","modified_gmt":"2024-12-12T01:17:26","slug":"nais-extends-use-of-medisaves-for-vaccines","status":"publish","type":"post","link":"https:\/\/www.medicare-asia.com\/en\/nais-extends-use-of-medisaves-for-vaccines\/","title":{"rendered":"NAIS, extends use of medisaves for vaccines"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"11581\" class=\"elementor elementor-11581\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ea2e269 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ea2e269\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7d7865d\" data-id=\"7d7865d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8cc47ae elementor-widget elementor-widget-text-editor\" data-id=\"8cc47ae\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.21.0 - 24-04-2024 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p>1.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 To facilitate the take up of important vaccinations amongst adults and help individuals make more informed decisions, the Ministry of Health (MOH) has established the National Adult Immunisation Schedule (NAIS) to provide guidance on vaccines that persons aged 18 years and older should adopt to protect themselves against vaccine-preventable diseases.\u00a0<\/p><p>2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 From 1 November 2017, Medisave can be used to pay for recommended vaccinations for the specific target adult population groups under the NAIS.\u00a0<\/p><p>3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Currently, the National Childhood Immunisation Programme (NCIP) aims to achieve herd immunity among children in the population and reduce the risk of disease outbreaks. With the NAIS, adults who have not been previously vaccinated or who are at risk will be able to make more informed choices on vaccination for personal protection. Together, the NAIS and NCIP provide comprehensive vaccination recommendations for Singaporeans and residents for all ages.\u00a0<\/p><p>4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Senior Minister of State for Health Dr Lam Pin Min said, \u201cVaccination provides a person with protection against infectious diseases, and is one of the strategies to reduce the risk of disease outbreaks in the community. While the coverage for vaccinations under the National Childhood Immunisation Programme has been high for most of the vaccines, there is low awareness of the benefits of adult vaccination for personal protection and protection of at-risk family members. With the introduction of the National Adult Immunisation Schedule (NAIS), we hope to encourage Singaporeans to take up the recommendations made in the NAIS, to protect themselves and their loved ones against the relevant infectious diseases.\u201d<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-09d00c4 elementor-widget elementor-widget-heading\" data-id=\"09d00c4\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.21.0 - 24-04-2024 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-xl\">Vaccines under NAIS\u00a0<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-10fcc3c elementor-widget elementor-widget-text-editor\" data-id=\"10fcc3c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"component-content\"><p>\u00a0<\/p><p>5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The NAIS will provide the public and healthcare professionals with information on the necessary vaccinations, targeted groups who should be vaccinated and frequency of vaccination. It was developed based on the recommendations of the national Expert Committee on Immunisation (ECI), and comprises seven types of vaccines that protect against 11 diseases, including:\u00a0<\/p><p>(i)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Influenza;<\/p><p>(ii)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pneumococcal (PCV13\/PPSV23);<\/p><p>(iii)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Human Papillomavirus (HPV2\/HPV4);<\/p><p>(iv)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tetanus, Diphtheria and Pertussis (Tdap);<\/p><p>(v)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Measles, Mumps and Rubella (MMR);<\/p><p>(vi)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hepatitis B; and<\/p><p>(vii)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Varicella.<\/p><p>6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 In deriving the recommendations, the ECI had examined the specific adult groups\u2019 vulnerability to vaccine-preventable diseases. Considerations include age, occupation, pre-existing medical conditions, vaccination history, as well as efficacy and cost effectiveness of the vaccines. Individuals are advised to discuss their vaccination needs and suitability to receive the recommended adult vaccines with their doctor.<\/p><p>7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MOH regularly reviews its vaccination policies in consultation with the national Expert Committee on Immunisation (ECI), taking reference from latest international best practice.\u00a0<\/p><\/div>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-717991b elementor-widget elementor-widget-heading\" data-id=\"717991b\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-xl\">Extension of Medisave<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-04300dc elementor-widget elementor-widget-text-editor\" data-id=\"04300dc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To enhance vaccination coverage and help Singaporeans pay for the recommended adult vaccines, Singaporeans will be able to use up to $400 of their Medisave per account, under the Medisave400 scheme, for all recommended vaccinations for the target adult population groups in the NAIS. This will take effect from 1 November 2017.<\/p><p>9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Singaporeans can use their Medisave for NAIS vaccinations at Medisave-accredited healthcare institutions, such as hospitals, polyclinics, and CHAS GP clinics. The list of recommended adult vaccinations and FAQ can also be found on https:\/\/www.moh.gov.sg\/NAIS.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5b2d239 elementor-widget elementor-widget-heading\" data-id=\"5b2d239\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-xl\">Summary of National Adult Immunisation Schedule (NAIS)<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d5c1c66 elementor-widget elementor-widget-text-editor\" data-id=\"d5c1c66\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><em>(For persons aged 18 years and older)<strong>\u00a0<\/strong><\/em><\/p><table class=\"table table-bordered\" style=\"width: 123%;\"><tbody><tr><td style=\"width: 44.7811%;\" valign=\"top\"><p><strong>Vaccine<\/strong><\/p><\/td><td style=\"width: 15.4882%;\" valign=\"top\"><p><strong>18-26 years<\/strong><\/p><\/td><td style=\"width: 15.1515%;\" valign=\"top\"><p><strong>27-64 years<\/strong><\/p><\/td><td style=\"width: 21.2121%;\" valign=\"top\"><p><strong>\u2265 65 years<\/strong><\/p><\/td><\/tr><tr><td style=\"width: 44.7811%;\" valign=\"top\"><p><strong>Influenza*<\/strong><\/p><\/td><td style=\"width: 30.6397%;\" colspan=\"2\" valign=\"top\"><p>1 dose annually<\/p><\/td><td style=\"width: 21.2121%;\" valign=\"top\"><p>1 dose annually<\/p><\/td><\/tr><tr><td style=\"width: 44.7811%;\" valign=\"top\"><p><strong>Pneumococcal*<sup>\u00a0\u2020<\/sup><\/strong><\/p><\/td><td style=\"width: 30.6397%;\" colspan=\"2\" valign=\"top\"><p>1 or 2 doses<strong><sup>\u00a7<\/sup><\/strong><\/p><\/td><td style=\"width: 21.2121%;\" valign=\"top\"><p>1 dose each<strong><sup>\u00a7<\/sup><\/strong><\/p><\/td><\/tr><tr><td style=\"width: 44.7811%;\" valign=\"top\"><p><strong>Human papillomavirus (HPV)<sup>\u2020<\/sup><\/strong><\/p><\/td><td style=\"width: 15.4882%;\" valign=\"top\"><p>3 doses<\/p><\/td><td style=\"width: 15.1515%;\" valign=\"top\"><p>\u00a0<\/p><\/td><td style=\"width: 21.2121%;\" valign=\"top\"><p>\u00a0<\/p><\/td><\/tr><tr><td style=\"width: 44.7811%;\" valign=\"top\"><p><strong>Tetanus, diphtheria and pertussis (Tdap)<sup>\u00b6<\/sup><\/strong><\/p><\/td><td style=\"width: 51.8518%;\" colspan=\"3\" valign=\"top\"><p>1 dose for each pregnancy<\/p><\/td><\/tr><tr><td style=\"width: 44.7811%;\" valign=\"top\"><p><strong>Measles, mumps and rubella (MMR)<sup>\u2020 \u00b6<\/sup><\/strong><\/p><\/td><td style=\"width: 51.8518%;\" colspan=\"3\" valign=\"top\"><p>2 doses<\/p><\/td><\/tr><tr><td style=\"width: 44.7811%;\" valign=\"top\"><p><strong>Hepatitis B<sup>\u2020<\/sup><\/strong><\/p><\/td><td style=\"width: 51.8518%;\" colspan=\"3\" valign=\"top\"><p>3 doses<\/p><\/td><\/tr><tr><td style=\"width: 44.7811%;\" valign=\"top\"><p><strong>Varicella<\/strong><\/p><\/td><td style=\"width: 51.8518%;\" colspan=\"3\" valign=\"top\"><p>2 doses<\/p><\/td><\/tr><\/tbody><\/table><p>\u00a0<\/p><table class=\"table table-bordered\"><tbody><tr><td valign=\"top\"><p>\u00a0<\/p><\/td><td valign=\"top\"><p>Recommended for adults who have not been previously vaccinated or lack evidence of past infection\/immunity<\/p><p>(Please consult your doctor for more details)<\/p><\/td><td valign=\"top\"><p>\u00a0<\/p><\/td><td valign=\"top\"><p>Recommended for adults with specific medical conditions and indications<\/p><p>(Please consult your doctor for more details)<\/p><\/td><\/tr><\/tbody><\/table><p><strong>\u00a0<\/strong><\/p><p>*\u00a0\u00a0 Also recommended for specific groups of children.<\/p><p>\u00a0\u00a0<strong><sup>\u2020<\/sup><\/strong>\u00a0\u00a0 Also included in the National Childhood Immunisation Schedule (NCIS).<\/p><p>\u00a0\u00a0<strong><sup>\u00a7<\/sup><\/strong>\u00a0\u00a0 Refer to next page for more details<\/p><p><strong><sup>\u00a0\u00a0 \u00b6<\/sup>\u00a0\u00a0\u00a0<\/strong>Protection against three diseases through one vaccination<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>National Adult Immunisation Schedule \u2013 recommended groups and vaccination schedule<br \/><\/strong><em>(For persons aged 18 years and older)\u00a0<\/em><\/p><table class=\"table table-bordered\"><tbody><tr><td valign=\"top\"><p><strong>Vaccines<\/strong><\/p><\/td><td valign=\"top\"><p><strong>Recommended Groups<\/strong><\/p><\/td><td valign=\"top\"><p><strong>Schedule<\/strong><\/p><\/td><\/tr><tr><td valign=\"top\"><p>Influenza*<\/p><\/td><td valign=\"top\"><p>\u2022 Persons aged 65 years or older;<\/p><p>\u2022 Persons aged 18 years and receiving long-term aspirin therapy;<\/p><p>\u2022 Persons who have chronic medical conditions such as diabetes mellitus, asthma, and heart disease;<\/p><p>\u2022 Persons who are immunocompromised;<\/p><p>\u2022 Persons receiving intermediate and long term care services;<\/p><p>\u2022 Women at all stages of pregnancy.<\/p><\/td><td valign=\"top\"><p>1 dose annually<\/p><\/td><\/tr><tr><td rowspan=\"2\" valign=\"top\"><p>Pneumococcal*<sup>\u00a0\u2020 \u00a7<\/sup><\/p><\/td><td valign=\"top\"><p>\u2022 Persons aged 65 years or older<\/p><\/td><td valign=\"top\"><p>1 dose each<sup>\u00b6<\/sup><\/p><\/td><\/tr><tr><td valign=\"top\"><p>\u2022 Persons aged 18 years and older with chronic illnesses such as chronic lung, heart, kidney or liver diseases and diabetes mellitus;<\/p><p>\u2022 Persons who are immunocompromised or with other medical conditions.**<\/p><\/td><td valign=\"top\"><p>1 or 2 doses<sup>\u2020\u2020<\/sup><\/p><p>\u00a0<\/p><p>\u00a0<\/p><\/td><\/tr><tr><td valign=\"top\"><p>Human papillomavirus (HPV)<sup>\u2020 \u00a7\u00a7<\/sup><\/p><\/td><td valign=\"top\"><p>\u2022 Females aged 18 to 26 years<\/p><\/td><td valign=\"top\"><p>3 doses (0, 1-2, 6 months)<\/p><\/td><\/tr><tr><td valign=\"top\"><p>Tetanus, diphtheria and pertussis (Tdap)<\/p><\/td><td valign=\"top\"><p>\u2022 Pregnant women (for each pregnancy)<\/p><\/td><td valign=\"top\"><p>1 dose per pregnancy<\/p><p>(16-32 weeks)<sup>\u00b6\u00b6<\/sup><\/p><\/td><\/tr><tr><td valign=\"top\"><p>Measles, mumps and rubella (MMR)<sup>\u2020<\/sup><\/p><\/td><td valign=\"top\"><p>\u2022 Adults without evidence of immunity and\/or prior disease<\/p><\/td><td valign=\"top\"><p>2 doses (0, 4 weeks)<\/p><\/td><\/tr><tr><td valign=\"top\"><p>Hepatitis B<sup>\u2020<\/sup><\/p><\/td><td valign=\"top\"><p>\u2022 Adults without evidence of immunity and\/or prior disease<\/p><\/td><td valign=\"top\"><p>3 doses (0, 1, 6 months)<\/p><\/td><\/tr><tr><td valign=\"top\"><p>Varicella<\/p><\/td><td valign=\"top\"><p>\u2022 Adults without evidence of immunity and\/or prior disease<\/p><\/td><td valign=\"top\"><p>2 doses (0, 4-8 weeks)<\/p><\/td><\/tr><\/tbody><\/table><p><strong>Contraindications<\/strong>:<\/p><p>Persons who have had severe allergic reaction after a previous vaccination or allergies to specific vaccine components\u00a0<strong>should not receive the vaccine<\/strong>, and those who are severely immunocompromised or are pregnant\u00a0<strong>should not receive live vaccines<\/strong>\u00a0such as MMR or varicella vaccines.\u00a0<\/p><p>* \u00a0 Also recommended for specific groups of children, including those with medical conditions or immunocompromised or with other rare conditions.<\/p><p><sup>\u00a0\u00a0 \u2020<\/sup>\u00a0\u00a0 Also included in the National Childhood Immunisation Schedule (NCIS)<\/p><p><sup>\u00a0\u00a0 \u00a7<\/sup>\u00a0\u00a0 Pneumococcal vaccines in the NAIS include 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23).<\/p><p><sup>\u00b6 \u00a0\u00a0<\/sup>One dose each of PCV13 and PPSV23 is recommended for persons aged 65 years and above.<\/p><p>** \u00a0 Other medical conditions include: Persons with cochlear implants or cerebrospinal fluid leaks; persons with anatomic or functional asplenia (including conditions such as homozygous sickle cell disease and coeliac syndrome that may lead to splenic dysfunction).<\/p><p><sup>\u2020\u2020<\/sup>\u00a0\u00a0 The number of recommended doses and vaccine type depend on medical condition and age. Please consult your doctor for more details.<\/p><p><sup>\u00a7\u00a7<\/sup>\u00a0\u00a0\u00a0 Also recommended for females aged 9 to 17 years. Two types of HPV vaccines are in the NAIS \u2013 bivalent HPV vaccine (HPV2) and quadrivalent HPV (HPV4) vaccine.<\/p><p><sup>\u00b6\u00b6<\/sup>\u00a0\u00a0 Tdap can also be considered for pregnant women after 32 weeks of gestation during each pregnancy. Please consult your doctor for more details.<\/p><p>\u00a0<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e2e4e29 elementor-widget elementor-widget-text-editor\" data-id=\"e2e4e29\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: left;\"><span style=\"font-family: arial, helvetica, sans-serif;\"><span style=\"font-weight: 400;\">Reference: <\/span><a href=\"https:\/\/www.moh.gov.sg\/news-highlights\/details\/moh-establishes-national-adult-immunisation-schedule-extends-use-of-medisave-for-vaccines-under-the-schedule\"><span style=\"font-weight: 400;\">Ministry of Health<\/span><\/a><\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e5ca179 elementor-widget elementor-widget-spacer\" data-id=\"e5ca179\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.21.0 - 24-04-2024 *\/\n.elementor-column .elementor-spacer-inner{height:var(--spacer-size)}.e-con{--container-widget-width:100%}.e-con-inner>.elementor-widget-spacer,.e-con>.elementor-widget-spacer{width:var(--container-widget-width,var(--spacer-size));--align-self:var(--container-widget-align-self,initial);--flex-shrink:0}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container,.e-con>.elementor-widget-spacer>.elementor-widget-container{height:100%;width:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer{height:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner{height:var(--container-widget-height,var(--spacer-size))}.e-con-inner>.elementor-widget-spacer.elementor-widget-empty,.e-con>.elementor-widget-spacer.elementor-widget-empty{position:relative;min-height:22px;min-width:22px}.e-con-inner>.elementor-widget-spacer.elementor-widget-empty .elementor-widget-empty-icon,.e-con>.elementor-widget-spacer.elementor-widget-empty .elementor-widget-empty-icon{position:absolute;top:0;bottom:0;left:0;right:0;margin:auto;padding:0;width:22px;height:22px}<\/style>\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a44b9e1 elementor-widget elementor-widget-heading\" data-id=\"a44b9e1\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h4 class=\"elementor-heading-title elementor-size-large\">Related Articles<\/h4>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-262dc68 elementor-widget elementor-widget-text-editor\" data-id=\"262dc68\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><a href=\"https:\/\/www.medicare-asia.com\/en\/national-vaccinations-for-children-and-adults\/\"><span style=\"font-family: arial, helvetica, sans-serif;\">National Vaccines for Child and Adults<\/span><\/a><\/p><p><a href=\"https:\/\/www.medicare-asia.com\/en\/why-vaccine-is-important-and-the-benefits-to-human-body\/\"><span style=\"font-family: arial, helvetica, sans-serif;\">Why Vaccine is important and benefits to the human body<\/span><\/a><\/p><p><a href=\"https:\/\/www.medicare-asia.com\/en\/national-immunisation-programme-in-singapore\/\"><span style=\"font-family: arial, helvetica, sans-serif;\">National Immunisation Programme in Singapore<\/span><\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>1.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 To facilitate the take up of important vaccinations amongst adults and help individuals make more informed decisions, the Ministry of Health (MOH) has established the National Adult Immunisation Schedule (NAIS) to provide guidance on vaccines that persons aged 18 years and older should adopt to protect themselves against vaccine-preventable diseases. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11598,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[37],"class_list":["post-11581","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthier-sg","tag-clinic"],"acf":[],"aioseo_notices":[],"rttpg_featured_image_url":{"full":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8.png",1080,1080,false],"landscape":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8.png",1080,1080,false],"portraits":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8.png",1080,1080,false],"thumbnail":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8-150x150.png",150,150,true],"medium":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8-300x300.png",300,300,true],"large":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8-1024x1024.png",1024,1024,true],"1536x1536":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8.png",1080,1080,false],"2048x2048":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8.png",1080,1080,false],"trp-custom-language-flag":["https:\/\/www.medicare-asia.com\/wp-content\/uploads\/2024\/04\/Vanda-Featured-Images-8-12x12.png",12,12,true]},"rttpg_author":{"display_name":"admin","author_link":"https:\/\/www.medicare-asia.com\/en\/author\/malik\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.medicare-asia.com\/en\/category\/healthier-sg\/\" rel=\"category tag\">Healthier SG<\/a>","rttpg_excerpt":"1.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 To facilitate the take up of important vaccinations amongst adults and help individuals make more informed decisions, the Ministry of Health (MOH) has established the National Adult Immunisation Schedule (NAIS) to provide guidance on vaccines that persons aged 18 years and older should adopt to protect themselves against vaccine-preventable diseases.&hellip;","_links":{"self":[{"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/posts\/11581","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/comments?post=11581"}],"version-history":[{"count":20,"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/posts\/11581\/revisions"}],"predecessor-version":[{"id":11772,"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/posts\/11581\/revisions\/11772"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/media\/11598"}],"wp:attachment":[{"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/media?parent=11581"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/categories?post=11581"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.medicare-asia.com\/en\/wp-json\/wp\/v2\/tags?post=11581"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}